Burden and Efficacy of Anticholinergic vs Mirabegron in Overactive Bladder - A Randomized Controlled Study

NCT07711808 · clinicaltrials.gov ↗

PHASE4

Phase

NOT_YET_RECRUITING

Status

208

Enrollment

OTHER

Sponsor class

Conditions

Overactive Bladder (OAB)

Interventions

DRUG: Solifencin
DRUG: Mirabegron

Sponsor

Universidade do Porto

Collaborators

[object Object]